Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...

Psoriasis results in long-term inflammation in the body. This inflammation stiffens and narrows the arteries, raising the ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Struggling with dark spots? Learn what causes hyperpigmentation, how to prevent it, and the best treatments—from skincare ...